MyLungCancerTeam

Yes, adjuvant chemotherapy can be given after surgery to help prevent non-small cell lung cancer (NSCLC) from returning. While it cannot guarantee the cancer won't come back, it can improve survival rates and increase the chances of better outcomes. This is especially important for early-stage cancer patients whose doctors Show Full Answer

Yes, adjuvant chemotherapy can be given after surgery to help prevent non-small cell lung cancer (NSCLC) from returning. While it cannot guarantee the cancer won't come back, it can improve survival rates and increase the chances of better outcomes. This is especially important for early-stage cancer patients whose doctors believe there's a high risk of recurrence. Common chemotherapy medications used for NSCLC include:
• Gemcitabine (Gemzar)
• Paclitaxel
• Pemetrexed (Alimta)
• Vinorelbine (Navelbine)
• Carboplatin
• Cisplatin
• Docetaxel
• Nab-paclitaxel

These medications work by targeting rapidly dividing cells throughout the body. They're typically given in cycles over about three weeks to allow recovery time between treatments. Additionally, newer treatment options like immunotherapy can help fight NSCLC. Immunotherapy works by helping your immune system recognize and attack cancer cells. Some common immunotherapy medications include:
• Atezolizumab (Tecentriq)
• Ipilimumab (Yervoy)
• Nivolumab (Opdivo)
• Pembrolizumab (Keytruda)

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Chemotherapy and Non-Small Cell Lung Cancer: What To Know

5 Treatment Types for Advanced NSCLC